cyclosporine and Parkinson Disease, Secondary

cyclosporine has been researched along with Parkinson Disease, Secondary in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's6 (66.67)18.2507
2000's2 (22.22)29.6817
2010's1 (11.11)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Avčin, S; Jazbec, J; Kojović, M; Miklavčič, P; Todorova, B; Trošt, M; Vipotnik Vesnaver, T1
Chiba, S; Freed, CR; Lee, YM; Zhou, W1
Caviedes, P; Couve, E; LeDoux, S; Paris, I; Perez-Pastene, C; Segura-Aguilar, J1
Earl, CD; Kupsch, A; Oertel, WH; Sautter, J1
Chen, XL; Gupta, M; Roisen, FJ1
Honig, LS; Wasserstein, PH1
Earl, CD; Kupsch, AR; Oertel, WH; Sauer, H; Schwarz, SC1
Kabuto, H; Makino, H; Matsuura, K; Ogawa, N1
Honey, CR; Shen, H1

Reviews

1 review(s) available for cyclosporine and Parkinson Disease, Secondary

ArticleYear
[Neuronal transplantation in animal models of Parkinson disease: in vivo voltammetry, tissue cryopreservation and immunology].
    Zentralblatt fur Neurochirurgie, 1995, Volume: 56, Issue:4

    Topics: Animals; Brain Tissue Transplantation; Cryopreservation; Cyclosporine; Disease Models, Animal; Dopamine; Fetal Tissue Transplantation; Graft Rejection; Humans; Immunosuppressive Agents; Mesencephalon; Parkinson Disease; Parkinson Disease, Secondary; Rats

1995

Other Studies

8 other study(ies) available for cyclosporine and Parkinson Disease, Secondary

ArticleYear
Cyclosporine A induced dystonia-parkinsonism.
    Journal of the neurological sciences, 2017, 04-15, Volume: 375

    Topics: Adolescent; Bone Marrow Transplantation; Brain; Cyclosporine; Diagnosis, Differential; Dyskinesia, Drug-Induced; Fatal Outcome; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Parkinson Disease, Secondary

2017
Noggin enhances dopamine neuron production from human embryonic stem cells and improves behavioral outcome after transplantation into Parkinsonian rats.
    Stem cells (Dayton, Ohio), 2008, Volume: 26, Issue:11

    Topics: Animals; Bone Morphogenetic Protein 4; Carrier Proteins; Cell Differentiation; Cell Line; Cell Survival; Cyclosporine; Dopamine; Embryonic Stem Cells; Gene Knock-In Techniques; Humans; Immunosuppressive Agents; Male; Neurons; Parkinson Disease, Secondary; Rats; SOXB1 Transcription Factors; Stereotyped Behavior; Stromal Cells

2008
Copper dopamine complex induces mitochondrial autophagy preceding caspase-independent apoptotic cell death.
    The Journal of biological chemistry, 2009, May-15, Volume: 284, Issue:20

    Topics: Animals; Apoptosis; Autophagy; Caspases; Cell Line; Copper; Cyclosporine; Dicumarol; DNA Fragmentation; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Enzyme Inhibitors; Humans; Mitochondria; NAD(P)H Dehydrogenase (Quinone); Occupational Exposure; Parkinson Disease, Secondary; Rats; Vacuoles

2009
The effect of prior in vitro exposure of donor cells to trophic factors in neurotransplantation.
    Experimental neurology, 1996, Volume: 138, Issue:1

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Cell Differentiation; Cricetinae; Cyclosporine; Male; Mice; Mice, Inbred C57BL; Nerve Growth Factors; Neurons; Parkinson Disease, Secondary; PC12 Cells; Rats; Tyrosine 3-Monooxygenase

1996
Parkinsonism during cyclosporine treatment.
    Bone marrow transplantation, 1996, Volume: 18, Issue:3

    Topics: Adult; Bone Marrow Transplantation; Cyclosporine; Female; Humans; Immunosuppressive Agents; Male; Parkinson Disease, Secondary

1996
Effects of graft pooling of foetal rat and mouse tissue and immunosuppression in the 6-hydroxydopamine rat model of Parkinson's disease.
    Experimental brain research, 1997, Volume: 115, Issue:1

    Topics: Animals; Behavior, Animal; Brain Tissue Transplantation; Cyclosporine; Female; Fetal Tissue Transplantation; Graft Survival; Immunosuppressive Agents; Mesencephalon; Mice; Mice, Inbred C57BL; Neostriatum; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Stereotyped Behavior; Sympatholytics; Transplantation, Heterologous; Tyrosine 3-Monooxygenase

1997
Initial cyclosporin A but not glucocorticoid treatment promotes recovery of striatal dopamine concentration in 6-hydroxydopamine lesioned mice.
    Neuroscience letters, 1997, Jul-25, Volume: 230, Issue:3

    Topics: Animals; Corpus Striatum; Cyclosporine; Disease Models, Animal; Dopamine; Glucocorticoids; Hydrocortisone; Immunosuppressive Agents; Male; Mice; Mice, Inbred ICR; Oxidopamine; Parkinson Disease, Secondary; Sympatholytics

1997
Immunosuppression for neural xenografts: a comparison of cyclosporin and anti-CD25 monoclonal antibody.
    Journal of neurosurgery, 1999, Volume: 91, Issue:1

    Topics: Animals; Antibodies, Monoclonal; Cyclosporine; Disease Models, Animal; Fetal Tissue Transplantation; Immunosuppression Therapy; Immunosuppressive Agents; Male; Mesencephalon; Mice; Parkinson Disease, Secondary; Rats; Rats, Wistar; Receptors, Interleukin-2; Transplantation, Heterologous; Treatment Outcome

1999